[HTML][HTML] Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic

E Rios-Guzman, LM Simons, TJ Dean, F Agnes…�- Nature�…, 2024 - nature.com
Abstract Respiratory Syncytial Virus (RSV) is a leading cause of acute respiratory tract
infection, with the greatest impact on infants, immunocompromised individuals, and older�…

Pediatric Respiratory Syncytial Virus Hospitalizations and Respiratory Support After the COVID-19 Pandemic

ZA Winthrop, JM Perez, SJ Staffa…�- JAMA Network�…, 2024 - jamanetwork.com
Importance After the COVID-19 pandemic, there was a surge of pediatric respiratory
syncytial virus (RSV) infections, but national data on hospitalization and intensive care unit�…

[HTML][HTML] Altered RSV epidemiology and genetic diversity following the COVID-19 pandemic

J Hultquist, E Rios-Guzman, L Simons, T Dean…�- Research�…, 2023 - ncbi.nlm.nih.gov
Abstract Respiratory Syncytial Virus (RSV) is a leading cause of acute respiratory tract
infection, with greatest impact on infants, immunocompromised individuals, and older adults�…

Pediatric Respiratory Syncytial Virus Hospitalizations, 2017-2023

T Fitzpatrick, SA Buchan, S Mahant, L Fu…�- JAMA Network�…, 2024 - jamanetwork.com
Importance Respiratory syncytial virus (RSV) transmission was disrupted worldwide
following the COVID-19 pandemic, and further study is required to better understand these�…

Changing clinical patterns and ear-nose-throat complications of seasonal viral respiratory tract infections.

M Săndulescu, O Săndulescu�- Germs, 2023 - search.ebscohost.com
The article focuses on the evolving clinical patterns and complications of seasonal viral
respiratory tract infections, particularly examining the impact of the COVID-19 pandemic on�…

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants

GB Gebretekle, MW Yeung, R Ximenes, A Cernat…�- medRxiv, 2024 - medrxiv.org
Abstract Background Health Canada recently authorized the RSVpreF pregnancy vaccine
and nirsevimab to protect infants against respiratory syncytial virus (RSV) disease. Objective�…

Hospital admissions for acute respiratory tract infections among infants from Nunavut and the burden of respiratory syncytial virus: a 10-year review in regional and�…

MLW Kinshella, J Allen, J Pawa, J Papenburg, R Jetty…�- medRxiv, 2024 - medrxiv.org
Background Nunavut is a northern Canadian territory in Inuit Nunangat (Inuit homeland in
Canada). Approximately 85% of the population identifies as Inuit. A high proportion of infants�…

The rapidly changing landscape of respiratory syncytial virus prophylaxis

JL Robinson, J Papenburg�- Journal of the Association of�…, 2023 - jammi.utpjournals.press
The introduction of nirsevimab (a respiratory syncytial virus [RSV] monoclonal antibody that
can protect for minimum 5 months with a single dose) and RSV maternal vaccines to protect�…

[PDF][PDF] Breakthroughs in the prevention of RSV disease among infants

RL Barbieri - cdn.mdedge.com
Respiratory syncytial virus (RSV) is a negative-sense, single-stranded, ribonucleic acid
(RNA) virus that is a member of Pneumoviridae family. Two subtypes, A and B, and multiple�…

Learn about RSV (Respiratory syncytial virus)

R Nose, L Fever - learn.canimmunize.ca
RSV | CANImmunize Knowledge Centre HomeMy Records Return to CANImmunize.ca Login
Create an Account Home My Records About About CANImmunizeFeaturesPublic Health�…